Latest Anticonvulsants Stories
The drug retigabine (trade name: Trobalt®) was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
The makers of three previously rejected weight loss drugs have resubmitted their products to the Food and Drug Administration (FDA) for approval, with each hoping to become the first new prescription anti-obesity drug to be approved in the U.S. in 13 years.
The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy.
Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures.
New research finds that when a person is experiencing a prolonged seizure, quick medical intervention is critical, becoming harder to stop the seizure with each passing minute, placing the patient at risk of severe brain damage and death.
In Jan 25th 2012, Abbott Laboratories (the company manufacturing Depakote) reported that 2011 selling, general and administrative expense report includes $1.5 billion of litigation reserves related
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.